Creation of a new and stronger Clariant with sales of approximately CHF 9 billion and an EBITDA margin of around 20 % in 2021
Intended transaction to combine Clariant’s Additives and high value Masterbatches with parts of SABIC’s Specialties business to form the Business Area High Performance Materials which will provide customers with significant benefits and strategic advantages
Remaining Plastics & Coatings business (Pigments, standard Masterbatches and Medical Specialties) to be divested by 2020
The new Clariant will benefit from an enhanced specialty portfolio, creating the basis to accelerate profitable growth and become a leading player in each of its Business Areas
Attractive prospects in Care Chemicals, Catalysis and Natural Resources with further improvements in margins
Clariant is a dedicated and strong partner providing innovative, specialized solutions for profitable growth and a sustainable tomorrow